comparemela.com

Latest Breaking News On - Paule kieny - Page 2 : comparemela.com

Regjeringen (via Public) / A Broader Basis for Making Decisions concerning Viral Vector Vaccines

A Broader Basis for Making Decisions concerning Viral Vector Vaccines The final decision concerning the use of the AstraZeneca and Janssen COVID-19 vaccines will be taken by the Norwegian Government. A committee of experts, both foreign and national, will be appointed to examine the consequences of using or not using these vaccines in the vaccination programme. The Norwegian Institute of Public Health recommends removing the AstraZeneca vaccine from the vaccination programme permanently due to the risk of rare but severe side effects. The Norwegian Institute of Public Health has assessed this in relation to the COVID-19 situation in Norway. The assessment made by the experts at the Norwegian Institute of Public Health is solid and thorough. Working with colleagues in Denmark, the Norwegian Institute of Public Health and the community of experts in Norway were quick to discover these side effects and assess the causal connection to the vaccine.

Merkel s party slumps on Covid woes as German polls loom: Global players brainstorm to boost vaccine output

World March 8, 2021 GENEVA: Global players are gathering online from Monday to brainstorm ways to rapidly boost vaccine production and fight a still-virulent coronavirus that has hobbled the world for 14 months. Giving impetus to the meeting is a warning from the Geneva-based World Health Organization (WHO) that the pandemic will not end unless poor countries can keep up with accelerating mass vaccination campaigns in rich nations. Meeting online on Monday and Tuesday will be partners of the Covax vaccine distribution initiative, led by the Gavi vaccine alliance and backed by research arm the Coalition for Epidemic Preparedness Innovations as well as the WHO.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.